Interventional cardiology: Antithrombotic drug and stent choices in primary PCI

Nat Rev Cardiol. 2011 Aug 9;8(9):483-4. doi: 10.1038/nrcardio.2011.108.
No abstract available

Publication types

  • News

MeSH terms

  • Angioplasty, Balloon, Coronary / adverse effects
  • Angioplasty, Balloon, Coronary / instrumentation*
  • Cardiovascular Agents / administration & dosage
  • Drug-Eluting Stents*
  • Fibrinolytic Agents / therapeutic use*
  • Hirudins
  • Humans
  • Myocardial Infarction / therapy*
  • Paclitaxel / administration & dosage
  • Peptide Fragments / therapeutic use*
  • Prosthesis Design
  • Randomized Controlled Trials as Topic
  • Recombinant Proteins / therapeutic use
  • Thrombosis / etiology
  • Thrombosis / prevention & control*
  • Time Factors
  • Treatment Outcome

Substances

  • Cardiovascular Agents
  • Fibrinolytic Agents
  • Hirudins
  • Peptide Fragments
  • Recombinant Proteins
  • Paclitaxel
  • bivalirudin